Issue 5, 2016

Synthesis and cytotoxic evaluation of several oleanolic acid–uracil/thymine conjugates

Abstract

A total of 16 targeted oleanolic acid–uracil/thymine hybrids were designed and synthesized as potential cytotoxic agents. Most IC50 values were under 10.0 μM, with some of them under 0.1 μM in vitro test against tested cells (Hep-G2, A549, BGC-823, MCF-7 and PC-3). These hybrids displayed much more potent inhibitory activities compared with oleanolic acid and commercial anticancer drug 5-fluorouracil (5-FU). The combination of fluorescence staining observation and flow cytometric analysis suggested that selected oleanolic acid–uracil hybrid 6a possessed clear cell apoptosis inducing effects. And the underlying mechanisms for the antitumor activity were associated with loss of the mitochondrial membrane potential, arrest of the Hep-G2 cell line at the G1 phase and activation of effector caspase-3/9 to trigger cell apoptosis.

Graphical abstract: Synthesis and cytotoxic evaluation of several oleanolic acid–uracil/thymine conjugates

Supplementary files

Article information

Article type
Research Article
Submitted
28 Jan 2016
Accepted
03 Mar 2016
First published
04 Mar 2016

Med. Chem. Commun., 2016,7, 972-981

Synthesis and cytotoxic evaluation of several oleanolic acid–uracil/thymine conjugates

K. Cheng, C. Su, J. Huang, H. Wang, J. Liu, Y. Zheng and Z. Chen, Med. Chem. Commun., 2016, 7, 972 DOI: 10.1039/C6MD00061D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements